Page last updated: 2024-12-08

acetylcodeine

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth

Cross-References

ID SourceID
PubMed CID5486550
CHEMBL ID3092043
SCHEMBL ID3476558
MeSH IDM0152119

Synonyms (24)

Synonym
morphinan-6-alpha-ol, 7,8-didehydro-4,5-alpha-epoxy-3-methoxy-17-methyl-, acetate
morphinan-6-ol, 7,8-didehydro-4,5-epoxy-3-methoxy-17-methyl-, acetate, (5alpha,6alpha)-
acetylcodeine
7,8-didehydro-4,5alpha-epoxy-3-methoxy-17-methylmorphinan-6alpha-ol acetate
6703-27-1
u59401etxh ,
unii-u59401etxh
6-o-acetyl codeine
codeine 6-acetate
CHEMBL3092043
SCHEMBL3476558
morphinan-6-ol, 7,8-didehydro-4,5-epoxy-3-methoxy-17-methyl-, 6-acetate, (5.alpha.,6.alpha.)-
morphinan-6-ol, o-acetyl-7,8-didehydro-4,5-epoxy-3-methoxy-17-methyl-, (5.alpha.,6.alpha.)-
acetylcodeine 0.1 mg/ml in acetonitrile
acetylcodeine 1.0 mg/ml in acetonitrile
bdbm224019
6alpha-acetoxy-4,5alpha-epoxy-3-methoxy-17-methyl-morphin-7-ene
6-acetil codeina
MFXFQKMUCYHPFQ-BKRJIHRRSA-N
DTXSID10985910
[(4r,4ar,7s,7ar,12bs)-9-methoxy-3-methyl-2,4,4a,7,7a,13-hexahydro-1h-4,12-methanobenzofuro[3,2-e]isoquinolin-7-yl] acetate
morphinan-6-ol,7,8-didehydro-4,5-epoxy-3-methoxy-17-methyl-,6-acetate,(5a,6a)-
PD166873
of - oral fluid samples

Research Excerpts

Dosage Studied

ExcerptRelevanceReference
" Methadone treatment was switched to SROM with flexible dosing and vice versa according to period and sequence of treatment."( Maintenance treatment for opioid dependence with slow-release oral morphine: a randomized cross-over, non-inferiority study versus methadone.
Backmund, M; Beck, T; Haasen, C; Reimer, J; Ruckes, C; Schuler, C; Verthein, U; Walcher, S, 2014
)
0.4
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Protein Targets (1)

Activation Measurements

ProteinTaxonomyMeasurementAverageMin (ref.)Avg (ref.)Max (ref.)Bioassay(s)
Mas-related G-protein coupled receptor member X2Homo sapiens (human)EC50 (µMol)22.00000.14003.73818.9000AID1802708; AID1802709
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023]

Biological Processes (6)

Processvia Protein(s)Taxonomy
sensory perception of painMas-related G-protein coupled receptor member X2Homo sapiens (human)
sleepMas-related G-protein coupled receptor member X2Homo sapiens (human)
positive regulation of cytokinesisMas-related G-protein coupled receptor member X2Homo sapiens (human)
mast cell degranulationMas-related G-protein coupled receptor member X2Homo sapiens (human)
mast cell activationMas-related G-protein coupled receptor member X2Homo sapiens (human)
G protein-coupled receptor signaling pathwayMas-related G-protein coupled receptor member X2Homo sapiens (human)
[Information is prepared from geneontology information from the June-17-2024 release]

Molecular Functions (3)

Processvia Protein(s)Taxonomy
G protein-coupled receptor activityMas-related G-protein coupled receptor member X2Homo sapiens (human)
neuropeptide bindingMas-related G-protein coupled receptor member X2Homo sapiens (human)
mast cell secretagogue receptor activityMas-related G-protein coupled receptor member X2Homo sapiens (human)
[Information is prepared from geneontology information from the June-17-2024 release]

Ceullar Components (2)

Processvia Protein(s)Taxonomy
membraneMas-related G-protein coupled receptor member X2Homo sapiens (human)
plasma membraneMas-related G-protein coupled receptor member X2Homo sapiens (human)
[Information is prepared from geneontology information from the June-17-2024 release]

Bioassays (22)

Assay IDTitleYearJournalArticle
AID1057807Displacement of [3H]diprenorphine from mu opioid receptor in HEK293 cells at 10 uM after 120 mins relative to control2013Bioorganic & medicinal chemistry, Dec-15, Volume: 21, Issue:24
Pivaloylcodeine, a new codeine derivative, for the inhibition of morphine glucuronidation. An in vitro study in the rat.
AID1057825Activity at UDP-glucuronosyltransferase in Sprague-Dawley rat liver microsomes assessed as morphine conversion to M3G at 1 uM by Michaelis-Menten plot analysis2013Bioorganic & medicinal chemistry, Dec-15, Volume: 21, Issue:24
Pivaloylcodeine, a new codeine derivative, for the inhibition of morphine glucuronidation. An in vitro study in the rat.
AID1057815Inhibition of UDP-glucuronosyltransferase in Sprague-Dawley rat liver microsomes assessed as morphine conversion to M3G after 30 mins by HPLC analysis2013Bioorganic & medicinal chemistry, Dec-15, Volume: 21, Issue:24
Pivaloylcodeine, a new codeine derivative, for the inhibition of morphine glucuronidation. An in vitro study in the rat.
AID1057823Activity at UDP-glucuronosyltransferase in Sprague-Dawley rat liver microsomes assessed as morphine conversion to M3G at 5 uM by Michaelis-Menten plot analysis2013Bioorganic & medicinal chemistry, Dec-15, Volume: 21, Issue:24
Pivaloylcodeine, a new codeine derivative, for the inhibition of morphine glucuronidation. An in vitro study in the rat.
AID1057824Activity at UDP-glucuronosyltransferase in Sprague-Dawley rat liver microsomes assessed as morphine conversion to M3G at 2.5 uM by Michaelis-Menten plot analysis2013Bioorganic & medicinal chemistry, Dec-15, Volume: 21, Issue:24
Pivaloylcodeine, a new codeine derivative, for the inhibition of morphine glucuronidation. An in vitro study in the rat.
AID1057808Displacement of [3H]diprenorphine from mu opioid receptor in HEK293 cells at 1 uM after 120 mins relative to control2013Bioorganic & medicinal chemistry, Dec-15, Volume: 21, Issue:24
Pivaloylcodeine, a new codeine derivative, for the inhibition of morphine glucuronidation. An in vitro study in the rat.
AID1057820Clearance in Sprague-Dawley rat liver microsomes at 1 uM2013Bioorganic & medicinal chemistry, Dec-15, Volume: 21, Issue:24
Pivaloylcodeine, a new codeine derivative, for the inhibition of morphine glucuronidation. An in vitro study in the rat.
AID1057822Activity at UDP-glucuronosyltransferase in Sprague-Dawley rat liver microsomes assessed as morphine conversion to M3G at 10 uM by Michaelis-Menten plot analysis2013Bioorganic & medicinal chemistry, Dec-15, Volume: 21, Issue:24
Pivaloylcodeine, a new codeine derivative, for the inhibition of morphine glucuronidation. An in vitro study in the rat.
AID1057803Displacement of [3H]U-69593 from kappa opioid receptor in CHO cells at 10 uM after 120 mins relative to control2013Bioorganic & medicinal chemistry, Dec-15, Volume: 21, Issue:24
Pivaloylcodeine, a new codeine derivative, for the inhibition of morphine glucuronidation. An in vitro study in the rat.
AID1057810Inhibition of UDP-glucuronosyltransferase in Sprague-Dawley rat hepatocytes assessed as morphine conversion to M3G at 5 to 40 uM incubated for 72 hrs prior to substrate addition measured after 2 hrs by HPLC analysis2013Bioorganic & medicinal chemistry, Dec-15, Volume: 21, Issue:24
Pivaloylcodeine, a new codeine derivative, for the inhibition of morphine glucuronidation. An in vitro study in the rat.
AID1057805Displacement of [3H]DADLE from delta opioid receptor in CHO cells at 1 uM after 120 mins relative to control2013Bioorganic & medicinal chemistry, Dec-15, Volume: 21, Issue:24
Pivaloylcodeine, a new codeine derivative, for the inhibition of morphine glucuronidation. An in vitro study in the rat.
AID1057818Clearance in Sprague-Dawley rat liver microsomes at 10 uM2013Bioorganic & medicinal chemistry, Dec-15, Volume: 21, Issue:24
Pivaloylcodeine, a new codeine derivative, for the inhibition of morphine glucuronidation. An in vitro study in the rat.
AID1057821Activity at UDP-glucuronosyltransferase in Sprague-Dawley rat liver microsomes assessed as morphine conversion to M3G at 50 uM by Michaelis-Menten plot analysis2013Bioorganic & medicinal chemistry, Dec-15, Volume: 21, Issue:24
Pivaloylcodeine, a new codeine derivative, for the inhibition of morphine glucuronidation. An in vitro study in the rat.
AID1057817Clearance in Sprague-Dawley rat liver microsomes at 5 uM2013Bioorganic & medicinal chemistry, Dec-15, Volume: 21, Issue:24
Pivaloylcodeine, a new codeine derivative, for the inhibition of morphine glucuronidation. An in vitro study in the rat.
AID1057806Displacement of [3H]DADLE from delta opioid receptor in CHO cells at 10 uM after 120 mins relative to control2013Bioorganic & medicinal chemistry, Dec-15, Volume: 21, Issue:24
Pivaloylcodeine, a new codeine derivative, for the inhibition of morphine glucuronidation. An in vitro study in the rat.
AID1057812Competitive inhibition of UDP-glucuronosyltransferase in Sprague-Dawley rat liver microsomes assessed as morphine conversion to M3G up to 5 uM by Lineweaver-Burk plot analysis2013Bioorganic & medicinal chemistry, Dec-15, Volume: 21, Issue:24
Pivaloylcodeine, a new codeine derivative, for the inhibition of morphine glucuronidation. An in vitro study in the rat.
AID1057813Inhibition of UDP-glucuronosyltransferase in Sprague-Dawley rat liver microsomes assessed as morphine conversion to M6G after 30 mins by HPLC analysis2013Bioorganic & medicinal chemistry, Dec-15, Volume: 21, Issue:24
Pivaloylcodeine, a new codeine derivative, for the inhibition of morphine glucuronidation. An in vitro study in the rat.
AID1057819Clearance in Sprague-Dawley rat liver microsomes at 2.5 uM2013Bioorganic & medicinal chemistry, Dec-15, Volume: 21, Issue:24
Pivaloylcodeine, a new codeine derivative, for the inhibition of morphine glucuronidation. An in vitro study in the rat.
AID1057816Clearance in Sprague-Dawley rat liver microsomes at 50 uM2013Bioorganic & medicinal chemistry, Dec-15, Volume: 21, Issue:24
Pivaloylcodeine, a new codeine derivative, for the inhibition of morphine glucuronidation. An in vitro study in the rat.
AID1057804Displacement of [3H]U-69593 from kappa opioid receptor in CHO cells at 1 uM after 120 mins relative to control2013Bioorganic & medicinal chemistry, Dec-15, Volume: 21, Issue:24
Pivaloylcodeine, a new codeine derivative, for the inhibition of morphine glucuronidation. An in vitro study in the rat.
AID1802709PRESTO-Tango Assay from Article 10.1038/nchembio.2334: \\In silico design of novel probes for the atypical opioid receptor MRGPRX2.\\2017Nature chemical biology, 05, Volume: 13, Issue:5
In silico design of novel probes for the atypical opioid receptor MRGPRX2.
AID1802708Intracellular Calcium Mobilization Assay from Article 10.1038/nchembio.2334: \\In silico design of novel probes for the atypical opioid receptor MRGPRX2.\\2017Nature chemical biology, 05, Volume: 13, Issue:5
In silico design of novel probes for the atypical opioid receptor MRGPRX2.
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (29)

TimeframeStudies, This Drug (%)All Drugs %
pre-19902 (6.90)18.7374
1990's4 (13.79)18.2507
2000's9 (31.03)29.6817
2010's11 (37.93)24.3611
2020's3 (10.34)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials1 (2.94%)5.53%
Reviews1 (2.94%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other32 (94.12%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]